TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets

Overview of attention for article published in Neurotherapeutics, February 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news: 1 news outlet
twitter: 5 X users

patent: 6 patents

Citations

dimensions_citation: 251 Dimensions

Readers on

mendeley: 662 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 6 patents that reference this research output.

METHODS OF TREATMENT, PREVENTION AND DIAGNOSIS

Application EP-3873461-A4

European Patent Office

Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF1

Grant US-11332504-B2

United States of America

Antisense oligonucleotide controlling expression amount of TDP-43 and use thereof

Grant US-11028390-B2

United States of America

Therapeutic or prophylactic composition for TDP-43 proteinopathy

Grant US-10612021-B2

United States of America

ANTISENSE OLIGONUCLEOTIDE CONTROLLING EXPRESSION AMOUNT OF TDP-43 AND USE THEREOF

Application WO-2019013141-A1

World Intellectual Property Organisation (WIPO)

TACROLIMUS FOR TREATING TDP-43 PROTEINOPATHY

Application WO-2017118857-A1

World Intellectual Property Organisation (WIPO)